What's Happening?
Sophie Gandsas, a behavioral neuroscience student at Northeastern University, completed a co-op at Massachusetts General Hospital (MGH) where she coordinated three studies on neurodegenerative prion disease. Inspired by her grandfather's struggle with
Parkinson's disease, Gandsas's work involved scheduling and interacting with participants, processing blood and cerebrospinal fluid samples, and performing cognitive tests. Prion disease is a rare and fatal group of disorders caused by misfolded proteins that damage nerve cells and create sponge-like holes in brain tissue, leading to dementia and death. The Centers for Disease Control and Prevention (CDC) states that prion disease affects approximately one to two people per million worldwide annually. While bovine spongiform encephalopathy (mad cow disease) is a known prion disease, it is uncommon, with only about 233 human cases since 1996. A small percentage (5% to 15%) of cases are hereditary due to a gene mutation, but the cause of about 85% of cases remains unknown, classified as 'sporadic' by the CDC. Prions were only identified in the 1980s, leading to historical misdiagnoses as Parkinson's disease.
Why It's Important?
This research is crucial because prion diseases are fatal, rare, and largely misunderstood, with no known cures or treatments currently available. The studies Gandsas assisted with, including an observational study of asymptomatic patients with a family history of the disease and two drug trials, aim to reduce prions in the brain. If successful, finding a way to lower prion protein amounts could have significant implications beyond prion disease, potentially impacting other neurodegenerative conditions like Alzheimer's disease, which share similar biological mechanisms. The lack of understanding surrounding the cause of most prion disease cases highlights the urgent need for continued research. Furthermore, the historical misdiagnosis of prion disease as other conditions like Parkinson's underscores the importance of accurate diagnostic tools and increased awareness within the medical community. The involvement of students like Gandsas in such critical research contributes to the development of future medical professionals equipped to tackle complex neurological disorders.
What's Next?
Gandsas plans to continue working part-time with the MGH researchers, indicating ongoing efforts in prion disease research. The observational study will continue to track asymptomatic patients annually for cognitive testing and biological sample collection to identify molecular signs of the disease. The drug trials will proceed with their goal of reducing prion protein replication, which could lead to potential treatments. The broader scientific community will likely continue to focus on understanding the mechanisms behind the 'sporadic' forms of prion disease and developing more effective diagnostic methods. The hope is that advancements in this field will eventually lead to cures and treatments for prion disease and potentially other neurodegenerative disorders, improving outcomes for patients who currently face a grim prognosis.
Beyond the Headlines
The dedication of individuals like Sophie Gandsas, driven by personal experiences, highlights the profound human element in scientific research. Her inspiration from her grandfather's illness underscores how personal connections can fuel critical scientific endeavors, transforming individual suffering into a catalyst for broader medical progress. The rarity of prion disease, coupled with its devastating impact, presents unique challenges for research funding and public awareness. This situation often means that breakthroughs rely heavily on the commitment of a relatively small community of researchers and advocates. The potential for findings in prion disease research to inform treatments for more common neurodegenerative diseases like Alzheimer's also points to the interconnectedness of biological mechanisms across different conditions, suggesting that insights gained from rare diseases can have far-reaching benefits for public health.
